BMS-212122 is an effective microsomal triglyceride transfer protein inhibitor (MTP inhibitor). MS-212122 was more effective than BMS-201038 in lowering blood lipid (cholesterol, VLDL/LDL, TG) in hamsters and crab-eating monkeys. Treatment with BMS-212122 resulted in a rapid decrease in plasma lipid levels and a significant decrease in lipid content and mononuclear cell-derived (CD68+) cells in atherosclerotic plaques compared to baseline and diet-diet controls.

194213-64-4

C43H36F6N4O2

754.76

BMS212122;BMS 212122;UNII-0Z473OO6GB;BMS-212122

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years